Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration
| Title: | Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration |
|---|---|
| Authors: | Leahey, Rebecca R.Aff1; Weber, MartinAff1; Cho, Chang HoonAff2; Hur, Seong KwonAff1; Cramer, AmberAff1; Manzanares, KarlaAff3; Babin, BrettAff3; Boenig, GladysAff4; Kring, TaylorAff5; Liu, LilingAff6; Cui, YusiAff6; Ganti, AnjaniAff6; Evans, John P.Aff7; Nespi, MarikaAff5; Ly, JustinAff6; Nugent, Alicia A.Aff2; Green, Samantha A.Aff8; Chan, Bryan K.Aff8; Hoogenraad, Casper C.Aff1; Delwig, AntonAff3, IDs44386025000234_cor1; Hinz, Flora I.Aff1, IDs44386025000234_cor2 |
| Source: | npj Drug Discovery. 2(1) |
| Database: | Springer Nature Journals |